Loading companies
Loading company profiles, tickers, sectors, and latest research coverage.
Loading company profiles, tickers, sectors, and latest research coverage.
Find company pages that collect related theses, catalysts, risks, filings, and discussion in one place.
Browse curated company pages by ticker, exchange, or research theme.
KeyCorp: regional-bank earnings need deposit and credit discipline
Open company ->Keysight: test-and-measurement cash flow needs cycle proof
Open company ->KHC: Brand scale still has to outrun impairment risk
Open company ->KKR: the asset-management machine still has to prove earnings quality through the cycle
Open company ->KMB: Kimberly-Clark needs proof portfolio reset work shows up in cash
Open company ->Kinder Morgan: the pipeline cash machine still lives under a leverage ceiling
Open company ->KO: Coke still has to prove pricing power can keep compounding cash
Open company ->Lucid: the luxury EV story still has to outrun the cash burn
Open company ->Leidos: the mission-tech contractor where backlog quality has to become cash
Open company ->LEN: Lennar needs housing-cycle proof that incentives convert to cash
Open company ->L3Harris: the defense electronics compounder still has to prove cash discipline
Open company ->Cheniere: LNG cash flow is powerful, but derivatives and debt still set the risk
Open company ->LRCX: wafer-fab upside still has to survive the memory cycle
Open company ->LULU: premium leggings need proof the growth story is not overstretched
Open company ->LVS: Macau and Singapore recovery still have to clear the cash-return test
Open company ->MAR: Marriott needs travel demand to keep converting into fee-rich cash flow
Open company ->Microchip: the embedded-chip recovery still has to rebuild operating leverage
Open company ->MCK: McKesson scale needs distribution margins to keep turning into cash
Open company ->MCO: ratings power still has to prove the debt cycle is friendly
Open company ->MongoDB: the database growth story still has to outrun GAAP losses
Open company ->Mondelez: snack brands have pricing power, but margins show the cost test
Open company ->Medtronic: the device giant has scale, but the proof is durable growth after reinvestment
Open company ->Neurocrine: the neuroscience cash engine still has to broaden beyond one franchise
Open company ->Norwegian Cruise Line: demand is back, but the debt stack still defines the equity story
Open company ->